Telesis Bio Implements Reverse Stock Split, Elects Directors

Telesis Bio (TBIO) has issued an announcement.

Telesis Bio Inc. announced a significant change to its stock structure following its 2024 annual stockholders’ meeting, implementing a 1-for-18 reverse stock split to take effect on May 9, 2024. This corporate action will consolidate every 18 current shares into a single share, reducing the total shares from around 30.1 million to 1.7 million, while leaving the authorized shares cap unchanged. Stockholders also voted in favor of key proposals, including electing three Class III directors and ratifying the company’s choice of independent auditor. Telesis Bio’s stock will continue to trade under the symbol “TBIO,” with a new CUSIP number post-split.

Find detailed analytics on TBIO stock on TipRanks’ Stock Analysis page.